Cargando…
The Role of VEGFA, COX2, HUR and CUGBP2 in Predicting the Response to Neoadjuvant Therapy in Rectal Cancer Patients
Background and objectives: The effectiveness of neoadjuvant therapy, which is commonly used for stage II-III rectal cancer (RC) treatment, is limited. Genes associated with the pathogenesis of RC could determine response to this treatment. Therefore, the aim of this study was to investigate the pote...
Autores principales: | Pauzas, Henrikas, Gyvyte, Ugne, Latkauskas, Tadas, Kairevice, Laura, Lizdenis, Paulius, Svagzdys, Saulius, Birgiolaite, Erika, Kuliaviene, Irma, Kupcinskas, Juozas, Tamelis, Algimantas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230171/ https://www.ncbi.nlm.nih.gov/pubmed/32331433 http://dx.doi.org/10.3390/medicina56040192 |
Ejemplares similares
-
Preoperative conventional chemoradiotherapy versus short-course radiotherapy with delayed surgery for rectal cancer: results of a randomized controlled trial
por: Latkauskas, Tadas, et al.
Publicado: (2016) -
Lack of association between miR-27a, miR-146a, miR-196a-2, miR-492 and miR-608 gene polymorphisms and colorectal cancer
por: Kupcinskas, Juozas, et al.
Publicado: (2014) -
miRNome Profiling and Functional Analysis Reveal Involvement of hsa-miR-1246 in Colon Adenoma-Carcinoma Transition by Targeting AXIN2 and CFTR
por: Lukosevicius, Rokas, et al.
Publicado: (2022) -
The impact of age on post-operative outcomes of colorectal cancer patients undergoing surgical treatment
por: Latkauskas, Tadas, et al.
Publicado: (2005) -
Microvessel density as new prognostic marker after radiotherapy in rectal cancer
por: Svagzdys, Saulius, et al.
Publicado: (2009)